These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9179790)

  • 21. Alzheimer's disease: from molecular biology to neuropsychiatry.
    Cummings JL
    Semin Clin Neuropsychiatry; 2003 Jan; 8(1):31-6. PubMed ID: 12567330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Alzheimer's disease: focus on beta-amyloid and gamma-secretase].
    Iwatsubo T
    Tanpakushitsu Kakusan Koso; 2004 May; 49(7 Suppl):1086-90. PubMed ID: 15168534
    [No Abstract]   [Full Text] [Related]  

  • 23. Beta-amyloid: Alzheimer's disease and brain beta-amyloidoses.
    Koudinova NV; Berezov TT; Koudinov AR
    Biochemistry (Mosc); 1999 Jul; 64(7):752-7. PubMed ID: 10424897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Excess of nicastrin in brain results in heterozygosity having no effect on endogenous APP processing and amyloid peptide levels in vivo.
    Brijbassi S; Amtul Z; Newbigging S; Westaway D; St George-Hyslop P; Rozmahel RF
    Neurobiol Dis; 2007 Feb; 25(2):291-6. PubMed ID: 17071095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease.
    El Tannir El Tayara N; Delatour B; Le Cudennec C; Guégan M; Volk A; Dhenain M
    Neurobiol Dis; 2006 Apr; 22(1):199-208. PubMed ID: 16337798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alzheimer's amyloid beta oligomers and lipoprotein apoAbeta: mistaken identity is possible.
    Koudinova NV
    Bioessays; 2003 Oct; 25(10):1024; author reply 1025. PubMed ID: 14505369
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse.
    Schenk D; Barbour R; Dunn W; Gordon G; Grajeda H; Guido T; Hu K; Huang J; Johnson-Wood K; Khan K; Kholodenko D; Lee M; Liao Z; Lieberburg I; Motter R; Mutter L; Soriano F; Shopp G; Vasquez N; Vandevert C; Walker S; Wogulis M; Yednock T; Games D; Seubert P
    Nature; 1999 Jul; 400(6740):173-7. PubMed ID: 10408445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Familial Alzheimer's disease.
    Rossor MN
    Baillieres Clin Neurol; 1992 Nov; 1(3):517-34. PubMed ID: 1344201
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pathogenesis of Alzheimer's disease].
    Alegre M; Noé E; Luquin MR
    Rev Med Univ Navarra; 1997; 41(1):46-57. PubMed ID: 9527714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial Alzheimer's disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid precursor protein carboxy-terminal fragment.
    Wiley JC; Hudson M; Kanning KC; Schecterson LC; Bothwell M
    J Neurochem; 2005 Sep; 94(5):1189-201. PubMed ID: 15992373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The etiology of Alzheimer's disease: the pathogenesis of dementia. The role of neurotoxins.
    Drachman DA; Lippa CF
    Ann N Y Acad Sci; 1992 May; 648():176-86. PubMed ID: 1637045
    [No Abstract]   [Full Text] [Related]  

  • 32. [Alzheimer's disease and the significance of amyloid-beta protein in its pathogenesis].
    Koch D; Abraham CR
    Harefuah; 1995 Feb; 128(3):156-9. PubMed ID: 7759006
    [No Abstract]   [Full Text] [Related]  

  • 33. Relationship of amyloid to Alzheimer's disease.
    Vinters HV
    West J Med; 1991 Jan; 154(1):94-5. PubMed ID: 2024520
    [No Abstract]   [Full Text] [Related]  

  • 34. Psychopharmacology of Alzheimer's disease.
    Procter AW
    Br J Hosp Med; 1996 Feb 21-Mar 5; 55(4):191-4. PubMed ID: 8777499
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug therapy in Alzheimer's disease.
    de la Torre J; Aliev G; Perry G
    N Engl J Med; 2004 Oct; 351(18):1911-3; author reply 1911-3. PubMed ID: 15509830
    [No Abstract]   [Full Text] [Related]  

  • 36. Pathophysiology and etiology of Alzheimer's disease.
    Burns EM; Buckwalter KC
    Nurs Clin North Am; 1988 Mar; 23(1):11-29. PubMed ID: 3279404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cdk5 deregulation in the pathogenesis of Alzheimer's disease.
    Cruz JC; Tsai LH
    Trends Mol Med; 2004 Sep; 10(9):452-8. PubMed ID: 15350898
    [No Abstract]   [Full Text] [Related]  

  • 38. Alzheimer's disease and angiogenesis.
    Agorogiannis EI; Agorogiannis GI
    Lancet; 2003 Apr; 361(9365):1299; author reply 1299-300. PubMed ID: 12699979
    [No Abstract]   [Full Text] [Related]  

  • 39. Cholinergic modulation of amyloid processing and dementia in animal models of Alzheimer's disease.
    Isacson O; Lin L
    Ann N Y Acad Sci; 2000; 920():309-14. PubMed ID: 11193169
    [No Abstract]   [Full Text] [Related]  

  • 40. [Alzheimer's disease: current viewpoints in the pathogenesis].
    Broere CA; Vogels OJ; Keyser AJ
    Ned Tijdschr Geneeskd; 1989 Oct; 133(42):2070-4. PubMed ID: 2682281
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.